Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | EP300 | Q09472 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.48 |
| ▸ | IDO1 | P14902 | 2/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.45 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.45 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.45 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NSD2 | O96028 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1648808 | 0.98 | HTT (0.61) | HTTLMNAEP300MAPTKDM4E | |
| SCHEMBL29462977 | 0.79 | CYP1A2 (0.43) | HTTLMNAEP300KDM4EGAA | |
| SCHEMBL1562090 | 0.79 | CYP1A2 (0.50) | LMNAEP300KDM4EGAAHSD17B10 | |
| SCHEMBL29999289 | 0.79 | CYP1A2 (0.50) | LMNAEP300KDM4EGAAHSD17B10 | |
| SCHEMBL866443 | 0.79 | CYP1A2 (0.43) | HTTLMNAEP300KDM4EGAA | |
| SCHEMBL352532 | 0.77 | PKM (0.63) | HTTLMNAEP300MAPTKDM4E | |
| Vitamin K3H2 SCHEMBL297164 | 0.77 | HTT (1.00) | HTTLMNAEP300MAPTKDM4E | |
| Vitamin K3H2 SCHEMBL29525544 | 0.77 | HTT (1.00) | HTTLMNAEP300MAPTKDM4E | |
| SCHEMBL4631028 | 0.77 | HTT (0.68) | HTTLMNAEP300MAPTKDM4E | |
| SCHEMBL29405295 | 0.77 | PKM (0.63) | HTTLMNAEP300MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724104-A1 | SYNERGISTIC COMPOSITION FOR ENHANCING THE SOLUBILITY, STABILITY, BIOAVAILABILTY AND IMMEDIATE RELEASE OF ACTIVE COMPOUNDS | Olene Life Sciences Private Limited (IN) | 2026-04-15 | — | — | EP | claimed |
| US-20250034321-A1 | COMPOSITIONS OF EPOXY CURING AGENT INCORPORATING NAPHTHOL AND NAPHTHOL DERIVATIVES | EVONIK OPERATIONS GMBH (DE) | 2025-01-30 | — | — | US | claimed |
| EP-4413058-A1 | COMPOSITIONS OF EPOXY CURING AGENT INCORPORATING NAPHTHOL AND NAPHTHOL DERIVATIVES | Evonik Operations GmbH (DE) | 2024-08-14 | — | — | EP | claimed |
| CN-118055962-A | Epoxy curing agent composition comprising naphthol and naphthol derivative | 赢创运营有限公司 | 2024-05-17 | — | — | CN | claimed |
| WO-2023057234-A9 | COMPOSITIONS OF EPOXY CURING AGENT INCORPORATING NAPHTHOL AND NAPHTHOL DERIVATIVES | EVONIK OPERATIONS GMBH (DE) | 2024-05-10 | — | — | WO | claimed |
| WO-2023057234-A1 | COMPOSITIONS OF EPOXY CURING AGENT INCORPORATING NAPHTHOL AND NAPHTHOL DERIVATIVES | EVONIK OPERATIONS GMBH (DE) | 2023-04-13 | — | — | WO | claimed |
| CN-115067522-A | Choline-containing multivitamin and mineral composition and preparation method and application thereof | 养生堂药业有限公司 | 2022-09-20 | — | — | CN | claimed |
| US-20220218781-A1 | COMPOSITION FOR ENHANCEMENT OF BIOAVAILABILITY OF PHYTOCHEMICALS AND PROCESS FOR PREPARATION THEREOF | OLENE LIFE SCIENCES PRIVATE LIMITED (IN) | 2022-07-14 | — | — | US | claimed |
| EP-4724104-A1 | SYNERGISTIC COMPOSITION FOR ENHANCING THE SOLUBILITY, STABILITY, BIOAVAILABILTY AND IMMEDIATE RELEASE OF ACTIVE COMPOUNDS | Olene Life Sciences Private Limited (IN) | 2026-04-15 | — | — | EP | disclosed |
| CN-118924714-B | MK-7-containing pharmaceutical composition, application and preparation method thereof | 广东新达瑞生物科技有限公司 | 2025-04-11 | — | — | CN | disclosed |
| WO-2025062177-A1 | SYNERGISTIC COMPOSITIONS OF SOLANUM LYCOPERSICUM L. EXTRACTS AND SELENIUM (SE), USEFUL FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA. | CENTRO DE INVESTIGACIÓN Y DE ESTUDIOS AVANZADOS DEL I.P.N. (MX) | 2025-03-27 | — | — | WO | disclosed |
| US-12226484-B2 | Compositions having improved bioavailability of therapeutics | TRx Biosciences Limited (GB) | 2025-02-18 | — | — | US | disclosed |
| US-20250034321-A1 | COMPOSITIONS OF EPOXY CURING AGENT INCORPORATING NAPHTHOL AND NAPHTHOL DERIVATIVES | EVONIK OPERATIONS GMBH (DE) | 2025-01-30 | — | — | US | disclosed |
| EP-3177275-B1 | COMPOSITION COMPRISING HYDROPHOBIC BIOLOGICALLY ACTIVE COMPOUNDS AND METHOD FOR PREPARING SAID COMPOSITION | ADVANCED BIONUTRITION CORP (US) | 2024-10-23 | — | — | EP | disclosed |
| WO-2000078278-A1 | ANHYDROUS ULTRAVIOLET LIGHT SCREENING COMPOSITION CONTAINING OCTOCRYLENE | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 2000-12-28 | — | — | WO | disclosed |
| EP-1060735-A1 | Anhydrous ultraviolet light screening composition containing octocrylene | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 2000-12-20 | — | — | EP | disclosed |
| EP-0117321-B1 | FOODSTUFFS, INCLUDING CHEWING GUM WITH ANTI-CARIES ACTIVITY, AND PROCESSES FOR PREPARING THEM | TABAGH AG (CH) | 1991-07-24 | — | — | EP | disclosed |
| EP-0117321-A2 | Foodstuffs, including chewing gum with anti-caries activity, and processes for preparing them | TABAGH AG (CH) | 1984-09-05 | — | — | EP | disclosed |
| US-4332884-A | USING A DIOXIME CHELATING AGENT | RICOH CO., LTD. (JP) | 1982-06-01 | — | — | US | disclosed |
| US-4306014-A | AMMONIA OR AMINES SUPPRESS THE COLOR-FORMING REACTION SYSTEM | RICOH CO., LTD. (JP) | 1981-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250034321-A1 | COMPOSITIONS OF EPOXY CURING AGENT INCORPORATING NAPHTHOL AND NAPHTHOL DERIVATIVES | SRM, PNMT, NIT2 | HTT 1810/4885LMNA 518/4885EP300 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.